Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:40:3-44.
doi: 10.1007/978-3-031-69491-2_1.

Biomarker Methodologies: A NIMH Perspective

Margaret C Grabb  1 , Linda S Brady  2
Affiliations
Review

Biomarker Methodologies: A NIMH Perspective

Margaret C Grabb et al. Adv Neurobiol. 2024.

Abstract

Biomarkers are critically important in the development of drugs, biologics, medical devices, and psychosocial interventions for psychiatric disorders. As the lead federal agency charged with setting and supporting the national agenda for mental health research, the National Institute of Mental Health (NIMH) funds a broad portfolio of basic, translational, and clinical research focused on identifying, developing, and validating biomarkers for serious mental illnesses and neurodevelopmental conditions. In psychiatric research over the past 10 years, there has been an intensive effort to identify biomarkers as potential tools to improve treatment options for individuals with mental health concerns and increase success in the development of novel interventions. This chapter highlights examples of biomarker technologies that have been utilized to advance understanding of the pathophysiology of psychiatric disorders and the development of novel therapeutics.

Keywords: Context of use; Drug development tools; Multicomponent biomarkers; Neurotechnologies; Public-private partnerships.

PubMed Disclaimer

References

    1. Abi-Dargham A, Javitch JA, Slifstein M, Anticevic A, Calkins ME, Cho YT, Fonteneau C, Gil R, Girgis R, Gur RE, et al. Dopamine D1R receptor stimulation as a mechanistic pro-cognitive target for schizophrenia. Schizophr Bull. 2022;48:199–210. https://doi.org/10.1093/schbul/sbab095 . - DOI - PubMed
    1. Agyeman AS, Bandukwala A, Bouri K, Hawes J, Krainak DM, Lababidi S, Mattes WB, Mishina EV, Turfle P, Wang SJ, Thekkudan T. US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers. Biomark Med. 2023;17:523–31. https://doi.org/10.2217/bmm-2023-0351 . - DOI - PubMed
    1. Alagaratnam J, von Widekind S, De Francesco D, Underwood J, Edison P, Winston A, Zetterberg H, Fidler S. Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis. BMJ Neurol Open. 2021;3:e000143. https://doi.org/10.1136/bmjno-2021-000143 . - DOI - PubMed - PMC
    1. Alem O. A wearable high-density MEG system with uOPMs. 2019. https://reporter.nih.gov/search/NBPr413HK02L5dl3_M7OXw/project-details/1... .
    1. AMP-Schizophrenia. Accelerating medicines partnership® schizophrenia. 2020. https://www.ampscz.org/ .